MedPath

A study to elucidate the clinical factors of contrast-enhanced MRI in prostate cancer clinical practice

Phase 4
Conditions
Prostate cancer
Registration Number
JPRN-UMIN000046470
Lead Sponsor
Department of Radiology, Kawasaki Medical School
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Male
Target Recruitment
400
Inclusion Criteria

Not provided

Exclusion Criteria

1.Patients who lack of imaging quality Investigator judged ineligible as a subject 2.Unevaluable of PI-RADS category due to lack of T2WI or DWI or DCE-MRI

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the correlation between clinicopathological and contrast enhancement, treatment evaluation, prediction of treatment effect and predicting prognosis after treatment by dynamic contrast-enhanced MRI.
Secondary Outcome Measures
NameTimeMethod
To evaluate the impact of dynamic contrast-enhanced MRI on practical clinical reading.
© Copyright 2025. All Rights Reserved by MedPath